Natus Medical, Inc.

BMR Examines Small-cap Med-tech Stocks: Align Technology, Zeltiq Aesthetics & Others

Natus Medical sees FY12 adjusetd EPS approx. 60c vs. consensus 63c

Natus Medical sees Q1 adjusted EPS approx. 7c vs. consensus 15c

Natus Medical (BABY) Offers FY12 and Q1 Guidance Below Expectations

Natus Medical Announces 2012 Annual and First Quarter Financial Guidance

Natus to Present at J.P. Morgan 30th Annual Healthcare Conference

Sleep Apnea Diagnostic Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

North America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Natus Medical Inc. (BABY) Vice President Finance and CFO Steven J Murphy sells 5,422 Shares

Camber Capital reports 7.02% passive stake in Natus Medical

Natus Medical requests withdrawal of registration statement

Broadfin Capital reports 5.1% passive stake in Natus Medical

Natus to Present at 23rd Annual Piper Jaffray Health Care Conference

Natus Medical Inc. Reports Operating Results (10-Q)

Natus Medical, Inc. (BABY) Reports In-Line Q3 EPS; Guides Q4, FY11 EPS ,Revs

Natus Medical sees FY11 EPS 48c vs. consensus 47c

Natus Medical sees Q4 EPS 15c vs. consensus 15c

Natus Medical reports Q3 EPS 7c vs. consensus 7c

Natus Medical Announces 2011 Third Quarter Financial Results

The 10 Highest Potential Returns in Medical Device Stocks

Natus Medical target lowered to $11 from $16 at Roth Capital

What's in a Name? For Stock Tickers, Plenty.

Allos, Alcoa, Nabors, Natus Medical, Skyline: U.S. Equity Movers

ThinkEquity, CL King Downgrade Natus Medical (BABY) Amid Outlook

Natus Medical Cuts Q3 Revenue Guidance; Stock Down 10% - Update

Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results

Shares of Natus Medical (BABY) to resume trading at 7:30am ET

Natus Medical sees FY11 revenue $234M vs. previous guidance $236M

Natus Medical expects Embla to contribute 8c to non-GAAP EPS in 2012

Natus Medical sees Q3 revenue approximately $51.5M vs. consensus $57.88M

Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results

Natus Medical CEO Hawkins says new goal is to have $500M in revenue in 2014

Natus Medical Buys Sleep Apnea Diagnostic Co

Natus Acquires Embla Systems For $16.1 Mln Cash - Update

Sleep apnea company Embla Systems sold

Natus Medical (BABY) Acquires Sleep Diagnostics Company Embla Systems for $16.1M Cash

Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company

Stifel Nicolaus Starts Natus Medical (BABY) at Hold

Natus Medical initiated with a Hold at Stifel Nicolaus

Natus Executives to Present at Upcoming Financial Conferences